ANGLE plc: Angle PLC Announces Concordance of Parsortix with

BREAKTHROUGH STUDY DEMONSTRATES FOR THE FIRST TIME CONCORDANCE OF PARSORTIX LIQUID BIOPSY BLOOD TEST WITH INVASIVE TISSUE BIOPSY OF THE METASTATIC SITEStudy explores key unmet medical need for metastatic

Related Keywords

United States , Mexico , Australia , Japan , India , Guildford , Western Australia , United Kingdom , China , Canada , London , City Of , Andrew Newland , Julie Lang , London Stock Exchange , Laboratory Developed Tests Ldts , University Of Southern California , Philips , University Of Southern California Norris Cancer Center , Breast Cancer Program , Norris Comprehensive Cancer Center , Company Parsortix , National Comprehensive Cancer Network , Southern California Norris Cancer , Surgical Oncology , Breast Surgery , Comprehensive Breast Cancer Program , Cleveland Clinic Cancer Center , Cancer Program , Associate Professor , Southern California , Chief Executive , Frequently Used Terms , Key Opinion Leaders , Laboratory Developed Tests , London Stock , Angle , Nnounces , Concordance , Parsortix , Issue , Biopsy ,